IFN-.beta.2/IL-6 receptor its preparation and pharmaceutical compositions containing it
US5216128A · kind A · utility
22Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 1990 |
| Grant date | Jun 1, 1993 |
| Priority date | — |
| Expiry date | May 30, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/834
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human natural IFN-.beta.2/IL-6 receptor and its soluble extracellular fragment are provided in substantially purified form and are shown to stimulate and to enhance beneficial effects of IFN-.beta.2/IL-6, such as its antiproliferative activity. Polyclonal and monoclonal antibodies raised against the soluble fragment of the receptor are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.